CAFs are activated by inflammatory mediators within the TME, encompassing soluble factors generated by the tumor, such as transforming growth factor beta (TGF-β), interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α)[6,7]. This evidence concerns the gene IL6 and neoplasm.